This excerpt taken from the EYE 8-K filed Apr 27, 2006.
Laser Vision Correction (LVC)
LVC sales were $61.0 million in the first quarter, up 14.4 percent versus the pro forma combined VISX LVC and AMO microkeratome sales in the year-ago period. The increase reflects primarily growth in the U.S. LVC business and increased sales related to the companys international expansion. Below are highlights of LVC categories for the first quarter of 2006. Growth rates reflect comparisons to the same period in 2005 and include the impacts of foreign currency.
Licensing and related sales of $40.6 million reflected an approximate 7.8 percent increase over VISX reported licensing and related sales in the same period last year. The improvement is attributed to an increase in the mix of CustomVueä LASIK procedures.
Systems sales of $10.9 million represented an approximate 42.3 percent increase over reported VISX system sales in the same period last year. The rise is due primarily to the increase in new unit placements in targeted international markets, as well as the continued rollout of Iris Registration in the U.S.
Service and parts sales in the first quarter were $6.2 million, an increase of approximately 2.5 percent compared to VISXs reported service and parts sales in the same period last year.